NetworkNewsBreaks Archive - Page 355 of 2163

ThursdayAug 22, 2024 1:00 pm

NetworkNewsBreaks – SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Offers Proactive Approach to Growing Rat Problem

SenesTech’s (NASDAQ: SNES) flagship product, Evolve(TM), has repeatedly demonstrated an effective rat control alternative to current market offerings. “The active ingredient in the product has been scientifically proven to reduce rodent fertility, ultimately offering a more proactive approach to addressing the growing rat problem, as opposed to a more reactive approach, as is the case with poisons and traps. The obvious argument is that it’s better to control reproduction than to kill rats after they are born,” reads a recent article. “The company’s offering also addresses the potential secondary impact of using poisons to control rat populations, given the harm…

ThursdayAug 22, 2024 12:58 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive 8-Week Body Weight Results from Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, is reporting on 8-week body weight results from its ongoing animal study WEIGHT-A24-1. According to the company, this is the only study carried out anywhere in the world today to evaluate the relative performance of liraglutide processed with DehydraTECH. The results show that DehydraTECH-liraglutide is outperforming DehydraTECH-semaglutide. In humans, semaglutide has been shown in other studies to be more than twice as effective at promoting weight loss as liraglutide. Thus, the announcement noted that the continued outperformance of DehydraTECH-liraglutide compared to DehydraTECH-semaglutide is of particular interest. Additionally, the…

ThursdayAug 22, 2024 12:44 pm

NetworkNewsBreaks – Starco Brands Inc. (STCB), DoorDash Collaborate in Special Autumn Whipshots Offer

Starco Brands(OTCQB: STCB), a developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, is partnering with DoorDash to deliver the ultimate fall treat. According to the announcement, DoorDash is now delivering STCB’s Whipshots(R), an innovative vodka-infused whipped cream brand cofounded by global superstar Cardi B. In addition, DoorDash customers who order Pumpkin Spice Whipshots will receive a $5 coffee credit added to their DoorDash account within two days of ordering; this offer ends Aug. 29, 2024. “We are excited to be working with DoorDash to help our fans experience a Pumpkin Spiked Latte – a…

ThursdayAug 22, 2024 10:54 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), American West Metals Release Update on Storm Cooper Project Drilling

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company exploring for high-grade copper and gold deposits in Virginia and Nunavut, Canada, is reporting on the drilling activities at the Storm Copper Project on Somerset Island, Nunavut. The exploration program is being conducted by American West Metals Limited. According to the update, the diamond drilling now intersects new zones of copper at depth as the deep search EM survey identifies a 1,300 meter by 500 meter anomaly for drill testing. Highlights of the drilling include a continued 100% hit rate for the deep diamond drilling with thick intervals…

ThursdayAug 22, 2024 10:22 am

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Subsidiary Secures Motor Carrier Authority, DOT Licenses

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, today announced that its wholly owned subsidiary, LE Logistics, LLC (LE”), has officially secured the Motor Carrier Authority (“MC”) and U.S. Department of Transport (“DOT”) licenses. This development positions LE to immediately launch its freight division under the Golden Triangle Ventures umbrella and sets the stage for a stronger and more compliant operational foundation. In addition, it positions LE to start operations with its initial fleet of assets under a brand-new, clean operating license. The licenses also prime LE to execute its strategy of operating a larger fleet of assets, driving…

WednesdayAug 21, 2024 2:19 pm

NetworkNewsBreaks – Core Scientific, Inc. (NASDAQ: CORZ) Repays $267M in Debt, Increases Cash on Hand on Recent Convertible Notes Issue

Core Scientific (NASDAQ: CORZ), a leader in digital infrastructure for bitcoin mining and high-performance computing, has repaid a total of $267 million in debt with proceeds from its recently closed convertible senior notes issue. According to the announcement, the company repaid $150 million in secured notes, $61 million in an exit facility and $56 million in miner equipment loans, in addition to interest and other fees. The repayment reduced interest rates from approximately 12.5% to 3%. The announcement noted that the convertible notes offering raised net proceeds of $172.8 million after all payments (including commissions and estimated offering expenses), significantly…

WednesdayAug 21, 2024 1:55 pm

NetworkNewsBreaks – Snap Inc. (NYSE: SNAP) Innovates to Boost User Engagement and Community Connections

Snap (NYSE: SNAP), the parent company behind the popular social media platform Snapchat, is making waves with its innovative approach to enhancing user engagement and deepening community connections. With a recent announcement of reaching 850 million monthly active users in the second quarter and over 11 million subscribers to Snapchat+, Snap is on a clear path to achieving its ambitious goal of 1 billion monthly users. This growth is underpinned by a series of new features and improvements aimed at making communication more expressive and engaging. The introduction of Map Reactions, Editable Chats, and My AI Reminders are just a few examples…

WednesdayAug 21, 2024 12:40 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Animal Study Results Supporting Potential Utility of DehydraTECH-CBD in Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced receipt of blood glucose results from weeks 4 and 8 of its ongoing animal study WEIGHT-A24-1. The study is underway using diabetic, pre-conditioned Zucker rats. The results showed that DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A and B) were the top performers in the study at day 56, reducing blood sugar levels by 2.50%, 1.90% and 1.53% respectively. These results appear to support Lexaria’s belief that DehydraTECH-CBD may have utility, particularly if used together with a GLP-1 drug, in diabetic control. Additionally, select DehydraTECH-CBD…

WednesdayAug 21, 2024 11:57 am

NetworkNewsBreaks – InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary to Begin Production of All-New Class 4 Commercial Truck in September

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors, its subsidiary, intends to begin production of saleable units of the Bollinger B4 Chassis Cab, an all-new Class 4 commercial EV truck, on September 16, 2024. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from its facility in Livonia, Michigan. According to the announcement, deliveries and revenue recognition of the B4 EV truck is expected to begin in October 2024. “We are already experiencing strong momentum in the market from important customers throughout the country,” commented Jim Connelly, chief…

WednesdayAug 21, 2024 11:57 am

NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Completes Manufacture, Filling of Intranasal Device for Use in Upcoming Clinical Trial

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, has completed its spray-dried formulation and filling of the nasal device for its lead candidate, ONP-002, for the treatment of concussion. A new chemical entity, ONP-002 targets the brain through delivery into the nasal cavity. According to the announcement, the prefilled formulation will be used to provide dosing for the upcoming phase 2a clinical trial in concussed patients. “In preparing for the phase 2a study, we wanted to ensure that ONP-002 could be formulated as a nanoparticle and delivered intranasally as a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks